Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-11-29

Clinical Trial Update: Eicosapentaenoic Free Fatty Acid and Fecal Calprotectin in Inflammatory Bowel Diseases [NA]

View source ↗

Summary

This clinical trial update notes that the study evaluating eicosapentaenoic free fatty acid and fecal calprotectin in inflammatory bowel diseases has completed,…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Eicosapentaenoic Free Fatty Acid (eicosapentaenoic acid)

Snippet

Sponsor: IRCCS Azienda Ospedaliero-Universitaria di Bologna | Conditions: Ulcerative Colitis, Crohn's Disease | NA | Status: COMPLETED